Top-News
Biotechnologie USA

Bio-Techne Corp News

Aktie
WKN:  A12ENG ISIN:  US09073M1045 US-Symbol:  TECH
77,21 $
-0,04 $
-0,05%
31.05.24 21:59:57
Handeln Depot/Watchlist
Aktienanzahl *
157,19 Mio.
Marktkapitalisierung *
11,19 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
S&P 500
IR-Website
zur Website
*Stand: 06.05.2024

Bio-Techne Corp News

31.05.24 - PR Newswire
BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES
BIO-​TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES PR Newswire
30.05.24 - PR Newswire
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE
BIO-​TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE PR Newswire
29.05.24 - PR Newswire
ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing
ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing PR Newswire
23.05.24 - PR Newswire
BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE
BIO-​TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE PR Newswire
22.05.24 - PR Newswire
BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY
BIO-​TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY ...
08.05.24 - PR Newswire
BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024
BIO-​TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024 PR Newswire
07.05.24 - PR Newswire
BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT)
BIO-​TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT) PR Newswire
01.05.24 - PR Newswire
BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
BIO-​TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS PR Newswire
01.05.24 - PR Newswire
BIO-TECHNE DECLARES DIVIDEND
BIO-​TECHNE DECLARES DIVIDEND PR Newswire
30.04.24 - PR Newswire
BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
BIO-​TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS PR Newswire
29.04.24 - PR Newswire
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
BIO-​TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC PR Newswire
26.04.24 - PR Newswire
BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY
BIO-​TECHNE AND NOVOMOL-​Dx ANNOUNCE POINT-​OF-CARE OCULAR BIOMARKER ASSAY PR Newswire
23.04.24 - PR Newswire
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
BIO-​TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS PR Newswire
10.04.24 - PR Newswire
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
BIO-​TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS PR Newswire
08.04.24 - PR Newswire
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
BIO-​TECHNE SURPASSES 10,000 PEER-​REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY PR Newswire
03.04.24 - PR Newswire
BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
BIO-​TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE PR Newswire
01.04.24 - PR Newswire
BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
BIO-​TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS PR Newswire
28.03.24 - PR Newswire
BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES
BIO-​TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES PR Newswire
22.03.24 - PR Newswire
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA
BIO-​TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA PR Newswire
12.03.24 - PR Newswire
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM
BIO-​TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM PR Newswire

Newssuche

Videos

29.05.24
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »